Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

A flurry of court documents have been filed this week in the case of Bryan Kohberger, the man charged in the killings of four ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

With the Texans signing off on two huge free agent deals and other giant contracts paid out by Cincinnati, Bears GM Ryan Poles has shown tremendous foresight.

Attacks on property carrying the logo of Elon Musk’s electric-car company are cropping up from coast to coast and even ...

The young man died of acute liver injury, a known side effect, Sarepta said in a statement. But the company said the “severity” of the patient’s case had not previously been seen with the therapy, ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Through his two-year, $3.97 million contact Travis Homer didn't do much for the Chicago Bears offense but they're bringing him back for a third season.

A New Mexico court has granted a temporary restraining order against the release of certain records related to the ...

Village Roadshow, producer and financier of The Matrix, Joker and Lego movie franchises, filed for bankruptcy protection amid ...